What is Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares?
, Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China.
HKPD · Verdict
Moderate reward · moderate risk
HKPD's standout is volatility; profitability and cash flow weigh on the picture.
Based on 88% data coverage
HKPD · Verdict
Top decile vs peers
-0% net margin · -1% ROE
2% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
, Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.59M.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.